Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

Overview of attention for article published in BMC Health Services Research, November 2015

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 93 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 25,233 followers.

RT @felly500: in this industry funded study dapagliflozin versus DPP-4 inhib was found to be v cost effective (sigh) https://t.co/eH1KQMsX1H

Reply Repost Favourite

in this industry funded study dapagliflozin versus DPP-4 inhib was found to be v cost effective (sigh) https://t.co/eH1KQMsX1H

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.